%0 Case Reports
%T A case of thoracic SMARCA4-Deficient undifferentiated tumor successfully treated with combination Ipilimumab-Nivolumab.
%A Nakano Y
%A Sekinada D
%A Kuze Y
%A Okamoto N
%A Gohma I
%A Yasuhara Y
%J Clin Case Rep
%V 10
%N 12
%D Dec 2022
%M 36523385
暂无%R 10.1002/ccr3.6745
%X Thoracic SMARCA4-deficient undifferentiated tumors are rare, with poor prognosis. A 73-year-old man presented to our hospital with dyspnea. Computed tomography-guided biopsy revealed a SMARCA4-deficient undifferentiated tumor. The patient was treated with combination ipilimumab-nivolumab. The tumor reduced in size after two courses.